merged_progeria-dna-base-editing.txt
<other>I need to carefully read through the article to find information about the researcher who worked with Dr. Liu and the FDA approval timeline.</other>

<question_number>1</question_number>
<answer>N/A</answer>

<other>The article mentions Nicole Gaudelli as a postdoctoral researcher in Dr. Liu's lab who produced the gene editing enzyme, but it doesn't state that she is leading the effort to apply this technology to human patients with progeria. The article indicates Dr. Collins and his team are leading that effort.</other>

<question_number>2</question_number>
<answer>N/A</answer>

<other>The article mentions Dr. Collins wants to start the trial in "two years or less" but doesn't provide any timeline for FDA approval of the base editing system for use in human patients, assuming the clinical trial is successful.</other>